Grant: Discovery Grants Program - Individual
McGill University
$27,910.00
Bacteriophage production using self-cycling fermentation technology
FY 2013-14
Summary
There is an increasing interest in the production of bacteriophages (phages), which can be used directly in phage therapy, diagnostics and as antibacterial agents and can also be used to produce recombinant proteins, which can be used as pharmaceuticals and in agriculture and food applications. The large scale production of phages is difficult. Self-cycling fermentation (SCF) was developed in my laboratories and is a method of growing microbes continuously, in synchronous culture. The work proposed here is an adaptation of SCF to significantly improve the production of phages. The research will apply a cycling strategy to the production of phages and, eventually, recombinant proteins having phages as vectors and adopt a novel control strategy which simplifies SCF and optimizes the production. The system will be developed as two independently cycling bioreactors. The first stage is used for the growth of the host and operates as a normal self-cycling fermentor (SCF). The second stage is used for the infection of the host by the phage and is called the self-cycling infection chamber (SCIC).An improvement over the original SCF control system is to use the analysis of CO2 levels in the exit gas. Preliminary work has show that this can capture all of the important features of both growth and the infection process. By analogy to normal SCF operation, this overall process is expected to be robust, reliable, and versatile (i.e. operational under various infection strategies). Another advantage of the SCF/SCIC is the possibility of obtaining a synchronized host population before its transfer into the SCIC. This would allow the age of the host at the time of infection to be used as a manipulated parameter. An important long term goal will be to use genetically modified phages, which can produce recombinant proteins. In the past, the use of phage for recombinant protein production has been discounted because of the difficulties in achieving large scale production of the phage. The SCF/SCIC will solve this crucial problem and make this approach feasible.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
6398-2008
Name nom
Cooper, David
Department département
Chemical Engineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2008
Award amount
27910
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
4
Committee name en
Chem. & Metallurgical Eng.
Committee name fr
Génies chimique et métal.
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Partie
5
Nb partie
5
Application title
Bacteriophage production using self-cycling fermentation technology
Keyword
NSERC
Application summary
There is an increasing interest in the production of bacteriophages (phages), which can be used directly in phage therapy, diagnostics and as antibacterial agents and can also be used to produce recombinant proteins, which can be used as pharmaceuticals and in agriculture and food applications. The large scale production of phages is difficult. Self-cycling fermentation (SCF) was developed in my laboratories and is a method of growing microbes continuously, in synchronous culture. The work proposed here is an adaptation of SCF to significantly improve the production of phages. The research will apply a cycling strategy to the production of phages and, eventually, recombinant proteins having phages as vectors and adopt a novel control strategy which simplifies SCF and optimizes the production. The system will be developed as two independently cycling bioreactors. The first stage is used for the growth of the host and operates as a normal self-cycling fermentor (SCF). The second stage is used for the infection of the host by the phage and is called the self-cycling infection chamber (SCIC).An improvement over the original SCF control system is to use the analysis of CO2 levels in the exit gas. Preliminary work has show that this can capture all of the important features of both growth and the infection process. By analogy to normal SCF operation, this overall process is expected to be robust, reliable, and versatile (i.e. operational under various infection strategies). Another advantage of the SCF/SCIC is the possibility of obtaining a synchronized host population before its transfer into the SCIC. This would allow the age of the host at the time of infection to be used as a manipulated parameter. An important long term goal will be to use genetically modified phages, which can produce recombinant proteins. In the past, the use of phage for recombinant protein production has been discounted because of the difficulties in achieving large scale production of the phage. The SCF/SCIC will solve this crucial problem and make this approach feasible.